Skip to main content
Fig.3 | Journal of Ovarian Research

Fig.3

From: Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR

Fig.3

Overview of predictive values of blood inflammatory composite markers in ovarian cancer and future research directions. NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; SII, systemic inflammation index; CAR, C-reactive protein-to-albumin ratio; PNI, prognostic nutritional index; OCP: ovarian cancer patients; EOCP: epithelial ovarian cancer patients; HGSOCP: high-grade serous ovarian carcinoma patients; OCCCP: ovarian clear cell carcinoma patients; CT, chemotherapy; NACT, neoadjuvant chemotherapy; OS, overall survival; PFS, progression-free survival; DFS, disease-free survival; DSS, disease-specific survival

Back to article page